gavel-istock-508411976_andreypopov

AndreyPopov / iStockphoto.com

15 January 2019Medtech

Boston Scientific and Edwards settle heart valve disputes

Boston Scientific and US-based Edwards Lifesciences have agreed to settle all outstanding patent litigation between the two companies.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

USPTO denies Edwards' MitraClip patent challenge

21 January 2020 The US Patent and Trademark Office has denied an inter partes review petition from Edwards Lifesciences, which argued that certain claims relating to Abbott’s MitraClip mitral valve repair device are unpatentable.

Federal Circuit resuscitates Snyder’s heart valve patent

16 October 2020 A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.

Boston Scientific secures nearly $160m in clips patents feud

13 June 2023 Win marks latest leg of cross-Atlantic litigation feud over devices that stop internal bleeding | Medical device maker garnered success against rival in the US and Germany but failed to secure an injunction in one European country.

More on this story

Boston Scientific secures nearly $160m in clips patents feud

13 June 2023 Win marks latest leg of cross-Atlantic litigation feud over devices that stop internal bleeding | Medical device maker garnered success against rival in the US and Germany but failed to secure an injunction in one European country.

USPTO denies Edwards' MitraClip patent challenge

21 January 2020 The US Patent and Trademark Office has denied an inter partes review petition from Edwards Lifesciences, which argued that certain claims relating to Abbott’s MitraClip mitral valve repair device are unpatentable.

Federal Circuit resuscitates Snyder’s heart valve patent

16 October 2020 A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.

More on this story

Boston Scientific secures nearly $160m in clips patents feud

13 June 2023 Win marks latest leg of cross-Atlantic litigation feud over devices that stop internal bleeding | Medical device maker garnered success against rival in the US and Germany but failed to secure an injunction in one European country.

USPTO denies Edwards' MitraClip patent challenge

21 January 2020 The US Patent and Trademark Office has denied an inter partes review petition from Edwards Lifesciences, which argued that certain claims relating to Abbott’s MitraClip mitral valve repair device are unpatentable.

Federal Circuit resuscitates Snyder’s heart valve patent

16 October 2020 A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.

More features

President Trump 2.0: Five major areas to watch

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?